Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|BMS-936561||MDX-1203||BMS-936561 is a human monoclonal anti-CD70 antibody in conjugation with a prodrug MED-A, which delivers cytotoxic effect to CD70 overexpressing cells (PMID: 25869904).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||BMS-936561||Phase I||Actionable||In a Phase I trial, BMS-936561 demonstrated safety and preliminary efficacy, resulted in stable disease in 69% (18/26) of patients with advanced solid tumors (PMID: 26576779).||26576779|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|